Table 2 Baseline characteristics
Baseline population (n = 883) | Arrhythmia recurrence after 1 year | p-value | ||
|---|---|---|---|---|
No (n = 541) | Yes (n = 342) | |||
Age (years), mean ± SD | 65.7 ± 11.5 | 65.1 ± 11.8 | 66.8 ± 10.9 | 0.029 |
Male gender, n (%) | 557 (63.1) | 353 (65.2) | 204 (59.6) | 0.093 |
Number of prior AF ablations, mean ± SD | 0.41 ± 0.81 | 0.37 ± 0.81 | 0.48 ± 0.79 | 0.046 |
Patients with paroxysmal atrial fibrillation, n (%) | 449 (50.8) | 295 (54.5) | 154 (45.0) | 0.007 |
Prior cardioversions, mean ± SD | 1.41 ± 1.77 | 1.20 ± 1.60 | 1.74 ± 1.96 | < 0.001 |
Diabetes, n (%) | 93 (10.5) | 53 (9.8) | 40 (11.7) | 0.361 |
Prior stroke/transient ischemic attack, n (%) | 71 (8.0) | 43 (7.9) | 28 (8.2) | 0.899 |
Vascular disease history, n (%) | 167 (18.9) | 100 (18.5) | 67 (19.6) | 0.869 |
Arterial hypertension, n (%) | 599 (67.8) | 364 (67.3) | 235 (68.7) | 0.745 |
Chronic heart failure history, n (%) | 109 (12.3) | 76 (14.0) | 33 (9.6) | 0.147 |
Glomerular filtration rate (mL/min), mean ± SD | 70.6 ± 21.8 | 71.6 ± 21.5 | 69.1 ± 22.1 | 0.108 |
BMI (kg/m2), mean ± SD | 27.5 ± 4.5 | 27.5 ± 4.5 | 27.6 ± 4.7 | 0.621 |
Group Ic and group III antiarrhythmic medication use, n (%) | 268 (30.4) | 165 (30.5) | 103 (30.1) | 0.235 |
Beta-blocker use, n (%) | 697 (78.9) | 419 (77.4) | 278 (81.3) | 0.173 |
LA diameter, mm, mean ± SD | 40.9 ± 6.4 | 40.3 ± 5.8 | 41.9 ± 7.2 | 0.005 |